ЕПІРУБІЦИН МЕДАК

उत्पाद अवलोकन

About ЕПІРУБІЦИН МЕДАК

ЕПІРУБІЦИН МЕДАК is a medication containing the active ingredient Epirubicin, a chemotherapeutic agent used in the treatment of various types of cancer. It belongs to the anthracycline class of drugs, which work by intercalating DNA strands and inhibiting the synthesis of nucleic acids, ultimately leading to cell death.

Key Benefits & Uses

• Treatment of breast cancer, particularly in patients with metastatic disease or those who have not responded to other therapies.
• Treatment of other types of cancer, including ovarian, lung, and stomach cancer, under the guidance of a healthcare professional.
• Combination therapy with other medications to enhance treatment outcomes in certain types of cancer.

Active Ingredient & Action

Epirubicin works by binding to DNA and inhibiting the enzyme topoisomerase II, which is essential for DNA replication and cell division. This leads to the formation of DNA breaks, ultimately resulting in cell death. The medication is primarily taken intravenously, and its effects are most pronounced in rapidly dividing cancer cells.

Important Notes

ЕПІРУБІЦИН МЕДАК should only be used under the guidance of a qualified healthcare professional. Patients should be closely monitored for signs of cardiotoxicity, myelosuppression, and other potential side effects. It is essential to follow the recommended dosage and administration schedule to minimize the risk of adverse reactions.